Salvo Health, a virtual clinic specializing in chronic gastrointestinal (GI) and metabolic health, raised $8.5 million in Series A funding.
ManchesterStory, City Light Capital, and Threshold Ventures co-led the investment round with participation from new investors, including The Artemis Fund, Contour Venture Partners, Owl Capital, and Impact X Capital Partners, and existing investors, including Human Ventures, Torch Capital, Felicis Ventures, and Alumni Ventures.
Latest News: One to One Health Raises $12M to Scale Up its Virtual Care Services
Salvo Health is emerging as the leader in helping gastrointestinal (GI) providers across the U.S. adopt a hybrid, AI-enhanced care model, offering brick & mortar clinics an easy-to-implement continuous care platform that saves time, increases revenue, and improves patient outcomes.
The startup ended 2025 having grown patients and revenue by 800% YoY, and enterprise agreements with GI doctors by more than 1,000%.
Latest News: Arik Ben Ishay Lands $50M for Digital Health Startup Biobeat Technologies
To date, Salvo Health has signed agreements with 801 GIs, representing 16% of all independent GIs in the U.S., to deploy wraparound care for their clinic patients. Some of its enterprise customers include; three of the four largest GI practices in the country, together seeing over 1.1 million GI patients a year across ten states.
Latest News: Zarminali Pediatrics Raises $110M to Expand its Pediatric Telehealth Services in the U.S.
“We invested in Salvo to expand access to ‘whole person’ care to communities across the country where there can be a shortage of GI providers and obstacles to finding world-class multidisciplinary, team-based care,” commented Matt Kinley, Founding Partner of venture capital firm ManchesterStory.
Latest News: OpenAI Acquires Healthcare IT Startup Torch Health